Tue, Jul 28, 2026 - Page 14
2404 indexed SquawkNews stories from this UTC day. Showing 1561-1679.
L
INSP Initiated Sell W/$39.00 PT at UBS
INSP Initiated Sell W/$39.00 PT at UBS
EQUITY | Jul 28, 2026, 11:49 AM UTC
L
IART Initiated Neutral W/$19.00 PT at UBS
IART Initiated Neutral W/$19.00 PT at UBS
EQUITY | Jul 28, 2026, 11:49 AM UTC
L
GXO Initiated Overweight W/$18.00 PT at Wells Fargo
GXO Initiated Overweight W/$18.00 PT at Wells Fargo
EQUITY | Jul 28, 2026, 11:49 AM UTC
L
GMED Initiated Neutral W/$82.00 PT at UBS
GMED Initiated Neutral W/$82.00 PT at UBS
EQUITY | Jul 28, 2026, 11:49 AM UTC
L
GKOS Initiated Neutral at UBS
GKOS Initiated Neutral at UBS
EQUITY | Jul 28, 2026, 11:49 AM UTC
L
EW Initiated Buy W/$110.00 PT at UBS
EW Initiated Buy W/$110.00 PT at UBS
EQUITY | Jul 28, 2026, 11:49 AM UTC
L
COO Initiated Neutral W/$75.00 PT at UBS
COO Initiated Neutral W/$75.00 PT at UBS
EQUITY | Jul 28, 2026, 11:49 AM UTC
L
BNTC Initiated Outperform W/$16.00 PT at Wedbush
BNTC Initiated Outperform W/$16.00 PT at Wedbush
EQUITY | Jul 28, 2026, 11:49 AM UTC
L
BLCO Initiated Buy at UBS
BLCO Initiated Buy at UBS
EQUITY | Jul 28, 2026, 11:49 AM UTC
L
BDX Initiated Buy W/$190.00 PT at UBS
BDX Initiated Buy W/$190.00 PT at UBS
EQUITY | Jul 28, 2026, 11:49 AM UTC
L
ATEX Initiated Buy W/$161.00 PT at Clear Street
ATEX Initiated Buy W/$161.00 PT at Clear Street
EQUITY | Jul 28, 2026, 11:49 AM UTC
L
ATEC Initiated Buy W/$15.00 PT at UBS
ATEC Initiated Buy W/$15.00 PT at UBS
EQUITY | Jul 28, 2026, 11:49 AM UTC
L
XOM Downgrade from Buy to Neutral W/$158.00 PT (from $154.00) at BOFA Securities
XOM Downgrade from Buy to Neutral W/$158.00 PT (from $154.00) at BOFA Securities
EQUITY | Jul 28, 2026, 11:49 AM UTC
L
RXO Downgrade from Hold to Sell W/$19.00 PT (from $24.00) at TD Cowen
RXO Downgrade from Hold to Sell W/$19.00 PT (from $24.00) at TD Cowen
EQUITY | Jul 28, 2026, 11:49 AM UTC
L
PINE Downgrade from Strong Buy to Outperform W/$22.00 PT at Raymond James
PINE Downgrade from Strong Buy to Outperform W/$22.00 PT at Raymond James
EQUITY | Jul 28, 2026, 11:49 AM UTC
L
LEVI Downgrade from Overweight to Equal Weight W/$25.00 PT at Wells Fargo
LEVI Downgrade from Overweight to Equal Weight W/$25.00 PT at Wells Fargo
EQUITY | Jul 28, 2026, 11:49 AM UTC
L
INTU Downgrade from Buy to Hold W/$304.00 PT (from $504.00) at TD Cowen
INTU Downgrade from Buy to Hold W/$304.00 PT (from $504.00) at TD Cowen
EQUITY | Jul 28, 2026, 11:49 AM UTC
L
FMS Downgrade from Neutral to Underperform W/$19.90 PT at BNP Paribas Exane
FMS Downgrade from Neutral to Underperform W/$19.90 PT at BNP Paribas Exane
EQUITY | Jul 28, 2026, 11:49 AM UTC
L
FBRX Downgrade from Overweight to Equalweight W/$77.00 PT (from $74.00) at Barclays
FBRX Downgrade from Overweight to Equalweight W/$77.00 PT (from $74.00) at Barclays
EQUITY | Jul 28, 2026, 11:49 AM UTC
L
EBC Downgrade from Overweight to Equal Weight at Stephens
EBC Downgrade from Overweight to Equal Weight at Stephens
EQUITY | Jul 28, 2026, 11:49 AM UTC
L
CRNX Downgrade from Buy to Neutral W/$85.00 PT (from $55.00) at UBS
CRNX Downgrade from Buy to Neutral W/$85.00 PT (from $55.00) at UBS
EQUITY | Jul 28, 2026, 11:49 AM UTC
L
CLX Downgrade from Buy to Hold W/$98.00 PT (from $125.00) at Jefferies
CLX Downgrade from Buy to Hold W/$98.00 PT (from $125.00) at Jefferies
EQUITY | Jul 28, 2026, 11:49 AM UTC
L
CAPR Downgrade from Buy to Neutral at Alliance Global Partners
CAPR Downgrade from Buy to Neutral at Alliance Global Partners
EQUITY | Jul 28, 2026, 11:49 AM UTC
L
BMRC Downgrade from Buy to Neutral at Brean Capital
BMRC Downgrade from Buy to Neutral at Brean Capital
EQUITY | Jul 28, 2026, 11:49 AM UTC
L
ACI Downgrade from Buy to Neutral W/$12.00 PT (from $20.00) at UBS
ACI Downgrade from Buy to Neutral W/$12.00 PT (from $20.00) at UBS
EQUITY | Jul 28, 2026, 11:49 AM UTC
L
SOLV Upgrade from Neutral to Buy W/$95.00 PT at UBS
SOLV Upgrade from Neutral to Buy W/$95.00 PT at UBS
EQUITY | Jul 28, 2026, 11:49 AM UTC
L
RELL Upgrade from Market Perform to Outperform W/$24.00 PT at Northland
RELL Upgrade from Market Perform to Outperform W/$24.00 PT at Northland
EQUITY | Jul 28, 2026, 11:49 AM UTC
L
NTR Upgrade from Neutral to Outperform W/$80.00 PT at BNP Paribas Exane
NTR Upgrade from Neutral to Outperform W/$80.00 PT at BNP Paribas Exane
EQUITY | Jul 28, 2026, 11:49 AM UTC
L
MGY Upgrade from Hold to Buy W/$33.00 PT at Truist Securities
MGY Upgrade from Hold to Buy W/$33.00 PT at Truist Securities
EQUITY | Jul 28, 2026, 11:49 AM UTC
L
MDT Upgrade from Neutral to Buy W/$100.00 PT at UBS
MDT Upgrade from Neutral to Buy W/$100.00 PT at UBS
EQUITY | Jul 28, 2026, 11:49 AM UTC
L
IP Upgrade from Neutral to Overweight W/$61.00 PT (from $51.00) at JPMorgan
IP Upgrade from Neutral to Overweight W/$61.00 PT (from $51.00) at JPMorgan
EQUITY | Jul 28, 2026, 11:49 AM UTC
L
HON Upgrade from Underperform to Neutral W/$265.00 PT (from $205.00) at BOFA Securities
HON Upgrade from Underperform to Neutral W/$265.00 PT (from $205.00) at BOFA Securities
EQUITY | Jul 28, 2026, 11:49 AM UTC
L
FLY Upgrade from N/A to Overweight W/$50.00 PT at KeyBanc
FLY Upgrade from N/A to Overweight W/$50.00 PT at KeyBanc
EQUITY | Jul 28, 2026, 11:49 AM UTC
L
CIB Upgrade from Neutral to Buy W/$98.00 PT (from $81.00) at Goldman Sachs
CIB Upgrade from Neutral to Buy W/$98.00 PT (from $81.00) at Goldman Sachs
EQUITY | Jul 28, 2026, 11:49 AM UTC
H
MergerBrief Daily: Deal News CHTR/LBRDA: CHTR Automatic Shelf Prospectus (Filing) OPFI/BNCC: Form S-4 Filed (S-4) NEE/D: Employee podcast tr
MergerBrief Daily: Deal News CHTR/LBRDA: CHTR Automatic Shelf Prospectus (Filing) OPFI/BNCC: Form S-4 Filed (S-4) NEE/D: Employee podcast transcript on integration planning and culture (PR) Global Infrastructure/AES: Aud
EQUITY | Jul 28, 2026, 11:47 AM UTC
L
BAX DXCM ENOV HSIC NUE OVV OZK TFII ABT AMZN ATRC BBNX BKR BSX CEG MCB NRG RXST SGHT TNDM VST PT changes @ UBS
BAX DXCM ENOV HSIC NUE OVV OZK TFII ABT AMZN ATRC BBNX BKR BSX CEG MCB NRG RXST SGHT TNDM VST PT changes @ UBS
EQUITY | Jul 28, 2026, 11:47 AM UTC
L
CMND - Clearmind Medicine Successfully Completes Part A of its FDA Regulated Phase I/II Trial
CMND - Clearmind Medicine Successfully Completes Part A of its FDA Regulated Phase I/II Trial
REGULATION | Jul 28, 2026, 11:47 AM UTC
L
CLX downgraded from Buy to Hold W/ $98 PT (from $125) @ JEFF
CLX downgraded from Buy to Hold W/ $98 PT (from $125) @ JEFF
EQUITY | Jul 28, 2026, 11:46 AM UTC
L
Kiniksa raises FY26 revenue view to $980M-$995M from $930M-$945M
Consensus $940.13M. The...
EARNINGS | Jul 28, 2026, 11:46 AM UTC
L
CVLT Commvault Systems RESULTS: Q1, Q1 arr $1.054B, Q1 REV $100M vs. EST $310.4M
CVLT Commvault Systems RESULTS: Q1, Q1 arr $1.054B, Q1 REV $100M vs. EST $310.4M
EARNINGS | Jul 28, 2026, 11:45 AM UTC
L
CVLT CVLT - Commvault Announces First Quarter Fiscal 2027 Financial Results
CVLT CVLT - Commvault Announces First Quarter Fiscal 2027 Financial Results
EARNINGS | Jul 28, 2026, 11:45 AM UTC
L
FMS downgraded fro Neutral to Underperform @ BNP
FMS downgraded fro Neutral to Underperform @ BNP
EQUITY | Jul 28, 2026, 11:45 AM UTC
L
LTRN Lantern Pharma to advance EMA-cleared phase 1B/2 trial of lp-184 (zirdafulven) in biomarker-selected advanced bladder cancer
LTRN Lantern Pharma to advance EMA-cleared phase 1B/2 trial of lp-184 (zirdafulven) in biomarker-selected advanced bladder cancer
EQUITY | Jul 28, 2026, 11:45 AM UTC
L
Kiniksa reports Q2 EPS 30c, consensus 28c
Reports Q2 revenue...
EARNINGS | Jul 28, 2026, 11:45 AM UTC
L
KGS new Overweight W/ $78 PT @ Piper
KGS new Overweight W/ $78 PT @ Piper
EQUITY | Jul 28, 2026, 11:44 AM UTC
L
REPL -21% premarket after FDA headlines
REPL -21% premarket after FDA headlines
REGULATION | Jul 28, 2026, 11:44 AM UTC
L
Japan Defense Force On Rescue Mission At Quake-Hit Mall - TBS
Japan Defense Force On Rescue Mission At Quake-Hit Mall - TBS
EQUITY | Jul 28, 2026, 11:43 AM UTC
L
CIB upgraded from Neutral to Buy W/ $98 PT (form $81) @ GSCO
CIB upgraded from Neutral to Buy W/ $98 PT (form $81) @ GSCO
EQUITY | Jul 28, 2026, 11:43 AM UTC
L
TE -9% premarket after preliminary results
TE -9% premarket after preliminary results
EQUITY | Jul 28, 2026, 11:43 AM UTC
L
AMZN - Business Insider earlier: Amazon overhauls its AI strategy, winding down most flagship models -Amazon is winding down most of its Nov
AMZN - Business Insider earlier: Amazon overhauls its AI strategy, winding down most flagship models -Amazon is winding down most of its Nova in-house AI models. -Amazon's AGI team was hit by layoffs. -SVP Peter DeSantis
EQUITY | Jul 28, 2026, 11:43 AM UTC
L
FBRX downgraded to EW from Overweight after ARGX M&A headlines @ BARC
FBRX downgraded to EW from Overweight after ARGX M&A headlines @ BARC
MNA | Jul 28, 2026, 11:42 AM UTC
L
SIGI Downgrade from Outperform to Market Perform W/$97.00 PT at BMO Capital
SIGI Downgrade from Outperform to Market Perform W/$97.00 PT at BMO Capital
EQUITY | Jul 28, 2026, 11:41 AM UTC
M
Is the AI Boom A 'Virtuous Circle' Or a Ponzi Scheme? Wall Street Is Split
The artificial intelligence boom has sparked a web of interwoven investments, leaving market watchers divided on whether this trend represents a “virtuous circle” of strategic alignment or a perilous tech echo chamber ma
RATES | Jul 28, 2026, 11:41 AM UTC
L
Dyne Therapeutics receives FDA clearance to initiate DYNE-302 trial
Dyne Therapeutics...
REGULATION | Jul 28, 2026, 11:41 AM UTC
L
TSLA ContourGlobal says Tesla signed a long-term agreement to buy 90% of Project Sterling’s electricity. The Arizona solar-and-storage
TSLA ContourGlobal says Tesla signed a long-term agreement to buy 90% of Project Sterling’s electricity. The Arizona solar-and-storage development is owned by KKR-backed ContourGlobal. Scheduled to begin operating
FX | Jul 28, 2026, 11:41 AM UTC
L
REPL FDA staff reviewers Flag concerns regarding Replimune's cancer drug trial ahead of July 30 advisory committee meeting - briefing docs
REPL FDA staff reviewers Flag concerns regarding Replimune's cancer drug trial ahead of July 30 advisory committee meeting - briefing docs
REGULATION | Jul 28, 2026, 11:41 AM UTC
L
PGNY downgraded to EW from OW, but raise PT to $34 from $27 @ BARC
PGNY downgraded to EW from OW, but raise PT to $34 from $27 @ BARC
EQUITY | Jul 28, 2026, 11:41 AM UTC
L
NVO high risk, high reward into Ph3 ZEUS CV readout @ BMO
NVO high risk, high reward into Ph3 ZEUS CV readout @ BMO
EQUITY | Jul 28, 2026, 11:41 AM UTC
L
PINE downgraded from Strong Buy to Outperform W/ $22 PT @ RAJA
PINE downgraded from Strong Buy to Outperform W/ $22 PT @ RAJA
EQUITY | Jul 28, 2026, 11:41 AM UTC
L
USO off lows
USO off lows
EQUITY | Jul 28, 2026, 11:40 AM UTC
L
AMZN Reiterate Outperform, top pick, $360 PT (from $355) – insatiable compute demand and resilient consumer @ BMO
AMZN Reiterate Outperform, top pick, $360 PT (from $355) – insatiable compute demand and resilient consumer @ BMO
EQUITY | Jul 28, 2026, 11:40 AM UTC
L
FSS - Federal Signal Corporation Declares Dividend of $0.15 per share
FSS - Federal Signal Corporation Declares Dividend of $0.15 per share
EQUITY | Jul 28, 2026, 11:40 AM UTC
L
TSLA - TESLA TO BUY POWER FROM KKR-BACKED ARIZONA SOLAR, BATTERY PLANT
TSLA - TESLA TO BUY POWER FROM KKR-BACKED ARIZONA SOLAR, BATTERY PLANT
EQUITY | Jul 28, 2026, 11:40 AM UTC
L
JBS upgraded from Neutral to Overweight W/ $18 PT @ JPMC
JBS upgraded from Neutral to Overweight W/ $18 PT @ JPMC
EQUITY | Jul 28, 2026, 11:40 AM UTC
L
XIFR xplr infrastructure: Q2 EPS from cont ops $0.40 - Q2 operating revenues $363M
XIFR xplr infrastructure: Q2 EPS from cont ops $0.40 - Q2 operating revenues $363M
EARNINGS | Jul 28, 2026, 11:39 AM UTC
H
KYIV Reiterate Buy and $20 PT heading into Q2 as expect Kyivstar stock to continue to benefit from exemplary underlying operating performanc
KYIV Reiterate Buy and $20 PT heading into Q2 as expect Kyivstar stock to continue to benefit from exemplary underlying operating performance coupled with heightened Frontier market investor interest in Ukraine @ Benchma
GEOPOLITICS | Jul 28, 2026, 11:39 AM UTC
H
Hubbell raises FY26 adjusted EPS view to $20.25-$20.55 from $19.30-$19.85
Consensus $19.97. The...
EARNINGS | Jul 28, 2026, 11:38 AM UTC
L
INTU downgraded from Buy to Hold W/ $304 PT (from $504) @ TDCowen
INTU downgraded from Buy to Hold W/ $304 PT (from $504) @ TDCowen
EQUITY | Jul 28, 2026, 11:38 AM UTC
L
RXO's valuation has become more attractive following the fallout from the Lipe V. Lupus Superior verdict, in which a jury awarded approximat
RXO's valuation has become more attractive following the fallout from the Lipe V. Lupus Superior verdict, in which a jury awarded approximately $604M against Lupus Superior, its driver, and CHRW @ Benchmark
EQUITY | Jul 28, 2026, 11:38 AM UTC
L
PHIN - PHINIA to Participate in Deutsche Bank Chicago Industrials Summit
PHIN - PHINIA to Participate in Deutsche Bank Chicago Industrials Summit
EQUITY | Jul 28, 2026, 11:38 AM UTC
L
BSP - Bending Spoons enters into €500 million SACE-backed term loan facility
BSP - Bending Spoons enters into €500 million SACE-backed term loan facility
EQUITY | Jul 28, 2026, 11:38 AM UTC
L
ESI maintain Outperform, top pick, $50 PT after results @ BMO
ESI maintain Outperform, top pick, $50 PT after results @ BMO
EQUITY | Jul 28, 2026, 11:38 AM UTC
L
BODI - The Beachbody Company, Inc. Announces Second Quarter 2026 Earnings Release Date, Conference Call, and Webcast
BODI - The Beachbody Company, Inc. Announces Second Quarter 2026 Earnings Release Date, Conference Call, and Webcast
EARNINGS | Jul 28, 2026, 11:38 AM UTC
L
LPRO - Open Lending and ANV Announce Results of Tender Offer
LPRO - Open Lending and ANV Announce Results of Tender Offer
EQUITY | Jul 28, 2026, 11:38 AM UTC
L
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout. re
RATES | Jul 28, 2026, 11:38 AM UTC
L
ACI downgraded from Buy to Neutral W/ $12 PT (from $20) @ UBS
ACI downgraded from Buy to Neutral W/ $12 PT (from $20) @ UBS
EQUITY | Jul 28, 2026, 11:38 AM UTC
L
Japan’s Minimum Wage For Fiscal 2026 Set To National Average Of 1,176 Yen, Up 55 Yen – Nikkei
READ HERE
EQUITY | Jul 28, 2026, 11:38 AM UTC
H
Hubbell reports Q2 adjusted EPS $5.52, consensus $5.38
Reports Q2 revenue...
EARNINGS | Jul 28, 2026, 11:37 AM UTC
L
GSK sees 2031 sales over GBP 40B
Accelerating growth from...
EQUITY | Jul 28, 2026, 11:37 AM UTC
L
Japan targets minimum wage of 1,176 Yen/hour for FY26 - Nikkei
Japan targets minimum wage of 1,176 Yen/hour for FY26 - Nikkei
FX | Jul 28, 2026, 11:36 AM UTC
L
TCOM Regulatory Reset, Long-Term Opportunity Remains; Buy @ Benchmark
TCOM Regulatory Reset, Long-Term Opportunity Remains; Buy @ Benchmark
EQUITY | Jul 28, 2026, 11:36 AM UTC
L
MPLT maintain Outperform, though lower PT to $20 (from $46) after ZEPHYR data setback @ BMO
MPLT maintain Outperform, though lower PT to $20 (from $46) after ZEPHYR data setback @ BMO
EQUITY | Jul 28, 2026, 11:36 AM UTC
L
GSK sees FY26 core EPS growth 7%-9%
Expect 2026 turnover...
EARNINGS | Jul 28, 2026, 11:36 AM UTC
L
XIFR xplr infrastructure: for 2026, expect portfolio to deliver adj EBITDA\nof $1.75B to $1.95B and fcfbg of $600M to $700M
XIFR xplr infrastructure: for 2026, expect portfolio to deliver adj EBITDA\nof $1.75B to $1.95B and fcfbg of $600M to $700M
EQUITY | Jul 28, 2026, 11:36 AM UTC
L
Paypal Q2 2026 Earnings
Paypal Q2 2026 Earnings
EARNINGS | Jul 28, 2026, 11:35 AM UTC
L
RMBS Reiterate Buy and $165 PT Following better-than-expected Q226 results and in line Q326 guidance, @ Benchmark
RMBS Reiterate Buy and $165 PT Following better-than-expected Q226 results and in line Q326 guidance, @ Benchmark
EARNINGS | Jul 28, 2026, 11:35 AM UTC
H
TTWO Reiterate Outperform, top pick, $285 PT into earnings @ BMO
TTWO Reiterate Outperform, top pick, $285 PT into earnings @ BMO
EARNINGS | Jul 28, 2026, 11:34 AM UTC
L
BA (more) Oper cash flow $1.36B, est. $687.7M
BA (more) Oper cash flow $1.36B, est. $687.7M
EQUITY | Jul 28, 2026, 11:34 AM UTC
L
HUBB Q2’26 EARNINGS HIGHLIGHTS Revenue: $1.71B (Est. $1.65B); +15% YoY Adj. EPS: $5.52 (Est. $5.38); +12% YoY Organic Net Sales Growth
HUBB Q2’26 EARNINGS HIGHLIGHTS Revenue: $1.71B (Est. $1.65B); +15% YoY Adj. EPS: $5.52 (Est. $5.38); +12% YoY Organic Net Sales Growth: +10%
EARNINGS | Jul 28, 2026, 11:34 AM UTC
L
YARW new Buy @ TDCowen
YARW new Buy @ TDCowen
EQUITY | Jul 28, 2026, 11:33 AM UTC
H
$BA Boeing Q2 Earnings
$BA Boeing Q2 Earnings
EARNINGS | Jul 28, 2026, 11:33 AM UTC
L
KURA Reiterate Market Outperform, $24 PT after investor event @ Citizens
KURA Reiterate Market Outperform, $24 PT after investor event @ Citizens
EQUITY | Jul 28, 2026, 11:33 AM UTC
H
USO OPEC+ expects to hold 2026 output steady after Sept: delegates
USO OPEC+ expects to hold 2026 output steady after Sept: delegates
ENERGY | Jul 28, 2026, 11:32 AM UTC
L
Red Sea Tanker Traffic Hits Multi-Month Low as Houthi Threat Holds
Red Sea Tanker Traffic Hits Multi-Month Low as Houthi Threat Holds
ENERGY | Jul 28, 2026, 11:31 AM UTC
L
KZIA Kazia Therapeutics announces the filing of provisional patent for novel strategy, supported by preclinical data, to prevent metastatic
KZIA Kazia Therapeutics announces the filing of provisional patent for novel strategy, supported by preclinical data, to prevent metastatic recurrence in triple-negative breast cancer
EQUITY | Jul 28, 2026, 11:31 AM UTC
L
GSK reports Q2 core EPS 50.5p, up 9% at CER
Reports Q2 revenue GBP...
EARNINGS | Jul 28, 2026, 11:31 AM UTC
H
Boeing reports Q2 core EPS (76c), consensus (31c)
Reports Q2 revenue...
EARNINGS | Jul 28, 2026, 11:31 AM UTC
H
Hubbell Lowers FY2026 GAAP EPS Guidance from $17.45-$18.00 to $17.25-$17.55 vs $17.78 Est
Hubbell (NYSE: HUBB ) lowers FY2026 GAAP EPS guidance from $17.45-$18.00 to $17.25-$17.55 vs $17.78 analyst estimate..
EARNINGS | Jul 28, 2026, 11:31 AM UTC
H
Hubbell Raises FY2026 Adj EPS Guidance from $19.30-$19.85 to $20.25-$20.55 vs $19.75 Est; Raises FY2026 Sales Guidance from $6.313B-$6.488B
Hubbell (NYSE: HUBB ) raises FY2026 Adj EPS guidance from $19.30-$19.85 to $20.25-$20.55 vs $19.75 analyst estimate. Raises FY2026 sales outlook from $6.313 billion-$6.488 billion to $6.780 billion-$6.897 billion vs $6.5
EARNINGS | Jul 28, 2026, 11:31 AM UTC
H
OPEC+ Expects To Hold 2026 Output Steady After Sept - Delegates
OPEC+ Expects To Hold 2026 Output Steady After Sept - Delegates
ENERGY | Jul 28, 2026, 11:31 AM UTC
L
Kiniksa Pharmaceuticals Raises FY2026 Sales Guidance from $930.000M-$945.000M to $980.000M-$995.000M vs $940.106M Est
Kiniksa Pharmaceuticals (NASDAQ: KNSA ) raises FY2026 sales outlook from $930.000 million-$945.000 million to $980.000 million-$995.000 million vs $940.106 million estimate.
EARNINGS | Jul 28, 2026, 11:30 AM UTC
L
BA BOEING 2Q CORE LOSS/SHR 76C, EST. LOSS/SHR 28C || 2Q ADJ FREE CASH FLOW $631M, EST. NEGATIVE $331.4M || 2Q CORE LOSS/SHR 76C || 2Q COMMER
BA BOEING 2Q CORE LOSS/SHR 76C, EST. LOSS/SHR 28C || 2Q ADJ FREE CASH FLOW $631M, EST. NEGATIVE $331.4M || 2Q CORE LOSS/SHR 76C || 2Q COMMERCIAL AIRPLANES REV. $11.75B, EST. $11.63B || 2Q REV. $24.56B, EST. $24.26B
EQUITY | Jul 28, 2026, 11:30 AM UTC
L
KNSA Kiniksa Pharmaceuticals RESULTS: Q2, Q2 operating expenses $216.406M, Q2 Net Income $25.432M, Q2 pretax profit $31.145M, Kiniksa Pharma
KNSA Kiniksa Pharmaceuticals RESULTS: Q2, Q2 operating expenses $216.406M, Q2 Net Income $25.432M, Q2 pretax profit $31.145M, Kiniksa Pharmaceuticals Earnings Notes:, - Kiniksa Pharmaceuticals Q2 product REV $243.6M
EARNINGS | Jul 28, 2026, 11:30 AM UTC
L
XIFR - XPLR Infrastructure, LP second-quarter 2026 financial results available on company's website
XIFR - XPLR Infrastructure, LP second-quarter 2026 financial results available on company's website
EARNINGS | Jul 28, 2026, 11:30 AM UTC
L
ZENA - ZenaTech’s ZenaDrone Begins Testing Phase for Interceptor P-1 Counter-UAS Drone Platform
ZENA - ZenaTech’s ZenaDrone Begins Testing Phase for Interceptor P-1 Counter-UAS Drone Platform
EQUITY | Jul 28, 2026, 11:30 AM UTC
L
DDD - 3D Systems Enables First FDA Clearance for Implant from a Point-of-Care Institution
DDD - 3D Systems Enables First FDA Clearance for Implant from a Point-of-Care Institution
REGULATION | Jul 28, 2026, 11:30 AM UTC
H
HUBB Hubbell RESULTS: Q2, Q2 REV $1,711.8M vs. EST $1.653B, Q2 EPS $4.52, Q2 Net Income $242.2M, Q2 ADJ EPS $5.52 vs. EST $5.38, Q2 operatin
HUBB Hubbell RESULTS: Q2, Q2 REV $1,711.8M vs. EST $1.653B, Q2 EPS $4.52, Q2 Net Income $242.2M, Q2 ADJ EPS $5.52 vs. EST $5.38, Q2 operating margin 20.4%, Q2 ADJ operating margin 23.9%, Q2 free cash flow $213M, Hubbell
EARNINGS | Jul 28, 2026, 11:30 AM UTC
L
BA FAA proposes to adopt new AD for Boeing planes, to inspect seat installation
BA FAA proposes to adopt new AD for Boeing planes, to inspect seat installation
EQUITY | Jul 28, 2026, 11:30 AM UTC
L
CAG - Conagra Brands Provides Senior Leadership Update
CAG - Conagra Brands Provides Senior Leadership Update
EQUITY | Jul 28, 2026, 11:30 AM UTC
L
HSCS Fortitude Energizes 12 MW Grand Island, Nebraska Facility, Expanding Owned-and-Operated Power Portfolio
HSCS Fortitude Energizes 12 MW Grand Island, Nebraska Facility, Expanding Owned-and-Operated Power Portfolio
EQUITY | Jul 28, 2026, 11:30 AM UTC
H
BA Boeing RESULTS: Q2, Q2 adj. EPS $-0.76 vs EST $-0.30, Q2 REV $24.56B vs EST $24.25B, Boeing Q2-end backlog $715B, Q2 non-GAAP free cash f
BA Boeing RESULTS: Q2, Q2 adj. EPS $-0.76 vs EST $-0.30, Q2 REV $24.56B vs EST $24.25B, Boeing Q2-end backlog $715B, Q2 non-GAAP free cash flow $631M, Boeing Earnings Notes:, Q2 results include $280M loss on air force on
EARNINGS | Jul 28, 2026, 11:30 AM UTC
L
PSTV - Plus Therapeutics Announces Scientific Presentations and Sponsored Symposium at 2026 SNO/ASCO CNS Metastases Conference - Click For R
PSTV - Plus Therapeutics Announces Scientific Presentations and Sponsored Symposium at 2026 SNO/ASCO CNS Metastases Conference
EQUITY | Jul 28, 2026, 11:30 AM UTC
L
ELAB - PMGC Holdings Inc. Announces Strategic Investment in Precision Aerospace & Defense Group and Long-Term Aerospace and Defense Manufact
ELAB - PMGC Holdings Inc. Announces Strategic Investment in Precision Aerospace & Defense Group and Long-Term Aerospace and Defense Manufacturing Agreement Through A&B Aerospace Inc.
EQUITY | Jul 28, 2026, 11:30 AM UTC
L
NICH - Why is NICH Moving This Fast? NutraVeri Signals Factory-Aligned Expansion After Early InTheZone Feedback from Military and Former NFL
NICH - Why is NICH Moving This Fast? NutraVeri Signals Factory-Aligned Expansion After Early InTheZone Feedback from Military and Former NFL Communities
EQUITY | Jul 28, 2026, 11:30 AM UTC
L
HBIO - Harvard Bioscience Schedules Second Quarter 2026 Earnings Conference Call for August 11, 2026 at 8:00 AM ET
HBIO - Harvard Bioscience Schedules Second Quarter 2026 Earnings Conference Call for August 11, 2026 at 8:00 AM ET
EARNINGS | Jul 28, 2026, 11:30 AM UTC
L
ALGR KM00 ALGRF - Algo Grande Provides Phase II Drill Update at Adelita; Copper Intersected in Skarn and Andesitic Porphyry at Cerro Grande
ALGR KM00 ALGRF - Algo Grande Provides Phase II Drill Update at Adelita; Copper Intersected in Skarn and Andesitic Porphyry at Cerro Grande
COMMODITIES | Jul 28, 2026, 11:30 AM UTC
L
ESAU ESAUF Z7D - ESGold Receives Exploration Authorization From Québec Government and Continues to Advance Its Permitted Tailings Reprocessi
ESAU ESAUF Z7D - ESGold Receives Exploration Authorization From Québec Government and Continues to Advance Its Permitted Tailings Reprocessing Project
EQUITY | Jul 28, 2026, 11:30 AM UTC
L
TRVI - Trevi Therapeutics to Participate in Upcoming August Conferences
TRVI - Trevi Therapeutics to Participate in Upcoming August Conferences
EQUITY | Jul 28, 2026, 11:30 AM UTC
L
NSRX - Nasus Pharma Appoints Pharmaceutical Industry Veteran Brendan P. O'Grady as Chief Executive Officer to Lead Strategic Growth - Click
NSRX - Nasus Pharma Appoints Pharmaceutical Industry Veteran Brendan P. O'Grady as Chief Executive Officer to Lead Strategic Growth
EQUITY | Jul 28, 2026, 11:30 AM UTC